Jeff Radwell
An editor has nominated this article for deletion. You are welcome to participate in the deletion discussion, which will decide whether or not to retain it. |
 | This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (November 2024) |
Jeff Radwell | |
|---|---|
| Born | Jeffrey Leo Radwell |
| Nationality | American |
| Education | University of Pennsylvania (BA) Imperial College London (PhD) |
| Known for | CEO and founder of Camouflet |
| Scientific career | |
| Fields | Immunology, molecular biology |
| Institutions | Imperial College London, New York University |
| Thesis | Molecular Basis of Chronic Inflammation-Driven Tumorigenesis: Modulation of NF-κB and STAT3 Signaling Pathways |
Jeff Radwell (born 1990) is an American executive and researcher who is the founder and CEO of Camouflet, a Los Angeles based software startup specializing in pricing solutions powered by artificial intelligence (AI).[1]
Early life and education
[edit]Radwell was raised near Philadelphia, PA in a family of educators. He also spent part of his childhood in the Chinese city of Guangzhou and special administrative regions of Hong Kong and Macau. He attended the George School.
He holds an undergraduate degree from the University of Pennsylvania, a Master of Business Administration from London Business School, and a Doctor of Philosophy from the Imperial College London Faculty of Medicine.[2]
Career
[edit]Early career
[edit]Beginning his academic career at the New York University Grossman School of Medicine,[3] Radwell focused his research on applying real-world data and machine learning algorithms to address significant public health questions amid the height of the COVID-19 pandemic.[4] This work was supported by funding from the National Institutes of Health (NIH), which provided resources in building operational infrastructure to facilitate the study's objectives through advanced data analysis.[5]
Radwell's efforts in developing novel machine learning algorithms and use of multivariate statistical methodologies led to the creation of the first computable phenotype for Long COVID, contributing to its formal definition.[6][7] His analytical approach harmonized data from three research networks within the NIH's "REsearching COVID to Enhance Recovery" (RECOVER) initiative: PCORnet Adult of Weill Cornell Medicine and PCORnet Pediatric of the Children's Hospital of Philadelphia, both funded by the Patient-Centered Outcomes Research Institute (PCORI), and the National COVID Cohort Collaborative (N3C), overseen by the National Center for Advancing Translational Sciences (NCATS).[8]
Camouflet
[edit]In 2024, Radwell founded Camouflet, a company whose flagship platform uses AI-driven analytics to respond to market fluctuations in real-time.[9] Radwell's vision for Camouflet was shaped by his research background and extensive experience in data analytics. He noted that “Camouflet’s technology shifts the pricing paradigm. Rather than adjusting prices periodically, our platform enables companies to respond instantly to market changes to seize opportunity and safeguard profitability." Radwell emphasized that "markets don’t wait, and neither should businesses."[10]
Personal life
[edit]Radwell lives in the Los Feliz neighborhood of Los Angeles, California.[11]
References
[edit]- ^ "Camouflet Unveils Next-Generation Dynamic Pricing Platform to Transform Market Competitiveness and Profitability". Yahoo Finance.
- ^ Yahoo Finance (November 4, 2024). "Camouflet Unveils Next-Generation Dynamic Pricing Platform to Transform Market Competitiveness and Profitability". Yahoo Finance.
- ^ Williams, Greg. "Sleep Apnea Associated with Increased Risk for Long COVID". NYU Langone Health.
- ^ Mandel, Hannah (May 11, 2023). "Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health record-based analysis from the RECOVER initiative". Sleep. 46 (9).
- ^ "Breathing Uneasy: Sleep Apnea Linked With Increased Long COVID Risks". SciTechDaily. May 11, 2023.
- ^ "Sleep apnea associated with increased risk for long COVID: Study suggests physicians may need to follow patients with both conditions more closely". Newswise. May 11, 2023.
- ^ Pfaff, Emily (May 16, 2022). "Identifying who has long COVID in the USA: a machine learning approach using N3C data" (PDF). The Lancet. 4.
- ^ "Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health record-based analysis from the RECOVER initiative". Johns Hopkins University. Johns Hopkins University.
- ^ "Camouflet Unveils Next-Generation Dynamic Pricing Platform". Canadian Insider. November 4, 2025.
- ^ "Profitability". Business Wire. November 4, 2024.
- ^ "2024 Harvard Club Annual Meeting and Awards Dinner". Harvard Club of Southern California. Harvard Alumni Association.